Table of Content

1. Executive Summary
1.1. Global Cosmetic Peptide Synthesis Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025 – 2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors – Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Product Adoption Analysis
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter’s Five Force Analysis
4. Global Cosmetic Peptide Synthesis Market Outlook:
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025–2032
4.3. Global Cosmetic Peptide Synthesis Market Outlook: Type
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Type, 2019 – 2023
4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2025 – 2032
4.3.3.1. Signal Peptides
4.3.3.2. Neurotransmitter Inhibitors
4.3.3.3. Carrier Peptides
4.3.3.4. Enzyme Inhibitor Peptides
4.3.3.5. Synthetic Antimicrobial Peptides (AMPs)
4.3.3.6. Others
4.3.4. Market Attractiveness Analysis: Type
4.4. Global Cosmetic Peptide Synthesis Market Outlook: Application
4.4.1. Introduction / Key Findings
4.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 – 2023
4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 – 2032
4.4.3.1. Hair/Eyelash/Eyebrow Care Series Peptide
4.4.3.2. Whitening Series Peptides
4.4.3.3. Anti-aging Series Peptides
4.4.3.4. Skin Renewal Series Peptides
4.4.3.5. Anti-allergic & Anti-Inflammatory Series Peptides
4.4.3.6. Slimming & Breast Enhancement Peptides
4.4.3.7. Others
4.4.4. Market Attractiveness Analysis: Application
4.5. Global Cosmetic Peptide Synthesis Market Outlook: End Product
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By End Product, 2019 – 2023
4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End Product, 2025 – 2032
4.5.3.1. Skin Care
4.5.3.1.1. Creams and Moisturizers
4.5.3.1.2. Sunscreen lotion
4.5.3.1.3. Serum
4.5.3.2. Hair care
4.5.3.2.1. Cream
4.5.3.2.2. Serum
4.5.3.3. Eye Care
4.5.3.3.1. Cream
4.5.3.3.2. Serum
4.5.3.4. Others
4.5.4. Market Attractiveness Analysis: End Product
4.6. Global Cosmetic Peptide Synthesis Market Outlook: End User
4.6.1. Introduction / Key Findings
4.6.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 – 2023
4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2032
4.6.3.1. Cosmetic Manufacturers
4.6.3.2. Cosmetic Contract Manufacturers
4.6.3.3. Biopharmaceutical Industries (Personal Care)
4.6.4. Market Attractiveness Analysis: End User
5. Global Cosmetic Peptide Synthesis Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 – 2023
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025 – 2032
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Cosmetic Peptide Synthesis Market Outlook:
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
6.2.1. By Country
6.2.2. By Type
6.2.3. By Application
6.2.4. By End Product
6.2.5. By End User
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2025 – 2032
6.4.1. Signal peptides
6.4.2. Neurotransmitter inhibitors
6.4.3. Carrier Peptides
6.4.4. Enzyme inhibitor Peptides
6.4.5. Synthetic Antimicrobial peptides (AMPs)
6.4.6. Others
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 – 2032
6.5.1. Hair/Eyelash/Eyebrow Care Series Peptide
6.5.2. Whitening Series Peptides
6.5.3. Anti-Aging Series Peptides
6.5.4. Skin Renewal Series Peptides
6.5.5. Anti-allergic & Anti-Inflammatory Series Peptides
6.5.6. Slimming & Breast Enhancement Peptides
6.5.7. Others
6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Product, 2025 – 2032
6.6.1. Skin Care
6.6.2. Hair Care
6.6.3. Eye Care
6.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2032
6.7.1. Cosmetic Manufacturers
6.7.2. Cosmetic Contract Manufacturers
6.7.3. Biopharmaceutical Industries (Personal Care)
6.8. Market Attractiveness Analysis
7. Europe Cosmetic Peptide Synthesis Market Outlook:
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
7.2.1. By Country
7.2.2. By Type
7.2.3. By Application
7.2.4. By End Product
7.2.5. By End User
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Türkiye
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2025 – 2032
7.4.1. Signal peptides
7.4.2. Neurotransmitter inhibitors
7.4.3. Carrier Peptides
7.4.4. Enzyme inhibitor Peptides
7.4.5. Synthetic Antimicrobial peptides (AMPs)
7.4.6. Others
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 – 2032
7.5.1. Hair/Eyelash/Eyebrow Care Series Peptide
7.5.2. Whitening Series Peptides
7.5.3. Anti-Aging Series Peptides
7.5.4. Skin Renewal Series Peptides
7.5.5. Anti-allergic & Anti-Inflammatory Series Peptides
7.5.6. Slimming & Breast Enhancement Peptides
7.5.7. Others
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Product, 2025 – 2032
7.6.1. Skin Care
7.6.2. Hair Care
7.6.3. Eye Care
7.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2032
7.7.1. Cosmetic Manufacturers
7.7.2. Cosmetic Contract Manufacturers
7.7.3. Biopharmaceutical Industries (Personal Care)
7.8. Market Attractiveness Analysis
8. East Asia Cosmetic Peptide Synthesis Market Outlook:
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
8.2.1. By Country
8.2.2. By Type
8.2.3. By Application
8.2.4. By End Product
8.2.5. By End User
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2025 – 2032
8.4.1. Signal peptides
8.4.2. Neurotransmitter inhibitors
8.4.3. Carrier Peptides
8.4.4. Enzyme inhibitor Peptides
8.4.5. Synthetic Antimicrobial peptides (AMPs)
8.4.6. Others
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 – 2032
8.5.1. Hair/Eyelash/Eyebrow Care Series Peptide
8.5.2. Whitening Series Peptides
8.5.3. Anti-Aging Series Peptides
8.5.4. Skin Renewal Series Peptides
8.5.5. Anti-allergic & Anti-Inflammatory Series Peptides
8.5.6. Slimming & Breast Enhancement Peptides
8.5.7. Others
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Product, 2025 – 2032
8.6.1. Skin Care
8.6.2. Hair Care
8.6.3. Eye Care
8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2032
8.7.1. Cosmetic Manufacturers
8.7.2. Cosmetic Contract Manufacturers
8.7.3. Biopharmaceutical Industries (Personal Care)
8.8. Market Attractiveness Analysis
9. South Asia & Oceania Cosmetic Peptide Synthesis Market Outlook:
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
9.2.1. By Country
9.2.2. By Type
9.2.3. By Application
9.2.4. By End Product
9.2.5. By End User
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2025 – 2032
9.4.1. Signal peptides
9.4.2. Neurotransmitter inhibitors
9.4.3. Carrier Peptides
9.4.4. Enzyme inhibitor Peptides
9.4.5. Synthetic Antimicrobial peptides (AMPs)
9.4.6. Others
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 – 2032
9.5.1. Hair/Eyelash/Eyebrow Care Series Peptide
9.5.2. Whitening Series Peptides
9.5.3. Anti-Aging Series Peptides
9.5.4. Skin Renewal Series Peptides
9.5.5. Anti-allergic & Anti-Inflammatory Series Peptides
9.5.6. Slimming & Breast Enhancement Peptides
9.5.7. Others
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Product, 2025 – 2032
9.6.1. Skin Care
9.6.2. Hair Care
9.6.3. Eye Care
9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2032
9.7.1. Cosmetic Manufacturers
9.7.2. Cosmetic Contract Manufacturers
9.7.3. Biopharmaceutical Industries (Personal Care)
9.8. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2032
9.8.1. Big Pharma/Biotech Companies
9.8.2. Smalls & Medium-size Pharma/Biotech Companies
9.8.3. Emerging/virtual Pharma Companies
9.8.4. Nutraceutical Companies
9.9. Market Attractiveness Analysis
10. Latin America Cosmetic Peptide Synthesis Market Outlook:
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
10.2.1. By Country
10.2.2. By Type
10.2.3. By Application
10.2.4. By End Product
10.2.5. By End User
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2025 – 2032
10.4.1. Signal peptides
10.4.2. Neurotransmitter inhibitors
10.4.3. Carrier Peptides
10.4.4. Enzyme inhibitor Peptides
10.4.5. Synthetic Antimicrobial peptides (AMPs)
10.4.6. Others
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 – 2032
10.5.1. Hair/Eyelash/Eyebrow Care Series Peptide
10.5.2. Whitening Series Peptides
10.5.3. Anti-Aging Series Peptides
10.5.4. Skin Renewal Series Peptides
10.5.5. Anti-allergic & Anti-Inflammatory Series Peptides
10.5.6. Slimming & Breast Enhancement Peptides
10.5.7. Others
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Product, 2025 – 2032
10.6.1. Skin Care
10.6.2. Hair Care
10.6.3. Eye Care
10.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2032
10.7.1. Cosmetic Manufacturers
10.7.2. Cosmetic Contract Manufacturers
10.7.3. Biopharmaceutical Industries (Personal Care)
10.8. Market Attractiveness Analysis
11. Middle East & Africa Cosmetic Peptide Synthesis Market Outlook:
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
11.2.1. By Country
11.2.2. By Type
11.2.3. By Application
11.2.4. By End Product
11.2.5. By End User
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2025 – 2032
11.4.1. Signal peptides
11.4.2. Neurotransmitter inhibitors
11.4.3. Carrier Peptides
11.4.4. Enzyme inhibitor Peptides
11.4.5. Synthetic Antimicrobial peptides (AMPs)
11.4.6. Others
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 – 2032
11.5.1. Hair/Eyelash/Eyebrow Care Series Peptide
11.5.2. Whitening Series Peptides
11.5.3. Anti-Aging Series Peptides
11.5.4. Skin Renewal Series Peptides
11.5.5. Anti-allergic & Anti-Inflammatory Series Peptides
11.5.6. Slimming & Breast Enhancement Peptides
11.5.7. Others
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Product, 2025 – 2032
11.6.1. Skin Care
11.6.2. Hair Care
11.6.3. Eye Care
11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2032
11.7.1. Cosmetic Manufacturers
11.7.2. Cosmetic Contract Manufacturers
11.7.3. Biopharmaceutical Industries (Personal Care)
11.8. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2025
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
12.3.1. Croda International Plc
12.3.1.1. Overview
12.3.1.2. Segments and Types
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Ashland
12.3.3. Bachem
12.3.4. Genscript Biotech Corp
12.3.5. BASF SE
12.3.6. Geltor
12.3.7. Lubrizol Corporation
12.3.8. Symrise
12.3.9. Bio basic Inc.
12.3.10. Regeron Inc.
12.3.11. Merck KGa
12.3.12. RS Synthesis, LLC
12.3.13. CSBio Company Inc.
12.3.14. Creative Peptides
12.3.15. Spec Chem Industry Inc.
12.3.16. LipoTrue, SL
12.3.17. Fibroheal
12.3.18. Seiwa Kasei Co., Ltd.
12.3.19. Silab
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations